Treatment of Basal Cell Carcinoma (BCC) of the Skin, of the Morpheiform, Infiltrative, and Noduloulcerative Types in Inoperable Patients and Not Suitable for Radiotherapy Using Formulated Methylene Blue
ENROLLING_BY_INVITATION
Status
Conditions
- Advanced Basal Cell Carcinoma (BCC)
- Inoperable Disease
- Morpheaform Basal Cell Carcinoma
- Noduloulcerative Basal Cell Carcinoma
- Infiltrative Basal Cell Carcinoma
Interventions
- DRUG: Formulated Topical Methylene Blue (0.5 mg/mL)
- DRUG: Wound Healing Gel
Sponsor
Daryoush Hamidi Alamdari, PhD